BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report)’s share price dropped 12.2% on Wednesday . The stock traded as low as $0.50 and last traded at $0.51. Approximately 103,655 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 110,983 shares. The stock had previously closed at $0.58.
BiomX Stock Up 10.8 %
The stock has a market cap of $9.90 million, a PE ratio of -0.15 and a beta of 1.31.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Further Reading
- Five stocks we like better than BiomX
- Top Stocks Investing in 5G Technology
- Tesla Investors Continue to Profit From the Trump Trade
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is a SEC Filing?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
